Jakko van Ingen
- Tuberculosis (out of print)Edited by Christoph Lange and Giovanni Battista MiglioriBook | Published in 2012DOI: 10.1183/1025448x.erm5812ISBN (electronic): 978-1-84984-028-6
- No human transmission of Mycobacterium malmoense in a perfect storm settingBy Wouter Hoefsloot, Martin J. Boeree, Cees van Nieuwkoop, Alexandra T. Bernards, Paul H.M. Savelkoul, Jakko van Ingen and Dick van SoolingenWouter Hoefsloot*Dept of Respiratory Diseases, Radboud University Nijmegen Medical CenterMartin J. Boeree*Dept of Respiratory Diseases, Radboud University Nijmegen Medical CenterCees van Nieuwkoop#Dept of Infectious Diseases, Leiden University Medical Center¶Dept of Internal Medicine, Haga Hospital, The HagueAlexandra T. Bernards+Dept of Medical Microbiology, Leiden University Medical Center, LeidenPaul H.M. Savelkoul§Dept of Medical Microbiology and Infection Control, VU University Medical Center, AmsterdamJakko van IngenfDept of Medical Microbiology, Radboud University Nijmegen Medical Center, NijmegenDick van SoolingenfDept of Medical Microbiology, Radboud University Nijmegen Medical Center, Nijmegen**National Mycobacteria Reference Laboratory, National Institute for Public Health and the Environment, Bilthoven, The Netherlands
- Re-think first-line tuberculosis treatmentBy Jakko van Ingen and Richard M. AnthonyJakko van Ingen*Dept of Medical Microbiology, Radboud University Nijmegen Medical Centre, NijmegenRichard M. Anthony#KIT Biomedical Research, Royal Tropical Institute, Amsterdam, The Netherlands
- The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative studyBy Wouter Hoefsloot, Jakko van Ingen, Claire Andrejak, Kristian Ängeby, Rosine Bauriaud, Pascale Bemer, Natalie Beylis, Martin J. Boeree, Juana Cacho, Violet Chihota, Erica Chimara, Gavin Churchyard, Raquel Cias, Rosa Daza, Charles L. Daley, P.N. Richard Dekhuijzen, Diego Domingo, Francis Drobniewski, Jaime Esteban, Maryse Fauville-Dufaux, Dorte Bek Folkvardsen, Noel Gibbons, Enrique Gómez-Mampaso, Rosa Gonzalez, Harald Hoffmann, Po-Ren Hsueh, Alexander Indra, Tomasz Jagielski, Frances Jamieson, Mateja Jankovic, Eefje Jong, Joseph Keane, Wo-Jung Koh, Berit Lange, Sylvia Leao, Rita Macedo, Turid Mannsåker, Theodore K. Marras, Jeannette Maugein, Heather J. Milburn, Tamas Mlinkó, Nora Morcillo, Kozo Morimoto, Dimitrios Papaventsis, Elia Palenque, Mar Paez-Peña, Claudio Piersimoni, Monika Polanová, Nalin Rastogi, Elvira Richter, Maria Jesus Ruiz-Serrano, Anabela Silva, M. Pedro da Silva, Hulya Simsek, Dick van Soolingen, Nora Szabó, Rachel Thomson, Teresa Tórtola Fernandez, Enrico Tortoli, Sarah E. Totten, Greg Tyrrell, Tuula Vasankari, Miguel Villar, Renata Walkiewicz, Kevin L. Winthrop and Dirk WagnerWouter Hoefsloot1W. Hoefsloot and J. van Ingen share first authorshipJakko van Ingen1W. Hoefsloot and J. van Ingen share first authorshipClaire AndrejakKristian ÄngebyRosine BauriaudPascale BemerNatalie BeylisMartin J. BoereeJuana CachoViolet ChihotaErica ChimaraGavin ChurchyardRaquel CiasRosa DazaCharles L. DaleyP.N. Richard DekhuijzenDiego DomingoFrancis DrobniewskiJaime EstebanMaryse Fauville-DufauxDorte Bek FolkvardsenNoel GibbonsEnrique Gómez-MampasoRosa GonzalezHarald HoffmannPo-Ren HsuehAlexander IndraTomasz JagielskiFrances JamiesonMateja JankovicEefje JongJoseph KeaneWo-Jung KohBerit LangeSylvia LeaoRita MacedoTurid MannsåkerTheodore K. MarrasJeannette MaugeinHeather J. MilburnTamas MlinkóNora MorcilloKozo MorimotoDimitrios PapaventsisElia PalenqueMar Paez-PeñaClaudio PiersimoniMonika PolanováNalin RastogiElvira RichterMaria Jesus Ruiz-SerranoAnabela SilvaM. Pedro da SilvaHulya SimsekDick van SoolingenNora SzabóRachel ThomsonTeresa Tórtola FernandezEnrico TortoliSarah E. TottenGreg TyrrellTuula VasankariMiguel VillarRenata WalkiewiczKevin L. Winthrop
- Pharmacokinetics and drug susceptibility testing imply limited activity of current regimens for Mycobacterium avium complex diseaseBy Jakko van Ingen, Martin Boeree, Charles Peloquin and Charles DaleyJakko van Ingen1Medical Microbiology, Radboud University Nijmegen Medical Center, Nijmegen, NetherlandsMartin Boeree1Medical Microbiology, Radboud University Nijmegen Medical Center, Nijmegen, NetherlandsCharles Peloquin1Medical Microbiology, Radboud University Nijmegen Medical Center, Nijmegen, NetherlandsCharles Daley1Medical Microbiology, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands
- The prevalence of pyrazinamide resistance in multidrug resistant tuberculosis cases in the NetherlandsBy Sami Simons, Jakko van Ingen, Martin Boeree and Dick Van SoolingenSami Simons1Respiratory Medicine, Radboud University Medical Centre, Nijmegen, NetherlandsJakko van Ingen2Medical Microbiology, Radboud University Medical Centre, Nijmegen, NetherlandsMartin Boeree1Respiratory Medicine, Radboud University Medical Centre, Nijmegen, NetherlandsDick Van Soolingen2Medical Microbiology, Radboud University Medical Centre, Nijmegen, Netherlands
- Pharmacokinetics of drugs for non tuberculous mycobacterial lung infectionsBy Cecile Magis-Escurra, Jakko van Ingen and Rob AarnoutseCecile Magis-Escurra1Pulmonary Diseases, University Medical Centre Nijmegen, UCCZ Dekkerswald, Groesbeek, Gelderland, NetherlandsJakko van Ingen1Pulmonary Diseases, University Medical Centre Nijmegen, UCCZ Dekkerswald, Groesbeek, Gelderland, NetherlandsRob Aarnoutse1Pulmonary Diseases, University Medical Centre Nijmegen, UCCZ Dekkerswald, Groesbeek, Gelderland, Netherlands
- The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: A NTM-NET collaborative studyBy W. Hoefsloot, Jakko van Ingen, C. Andrejak, K. Ängeby, R. Bauriaud, P. Bemer, N. Beylis, M.J. Boeree, J. Cacho, V. Chihota, E. Chimara, G. Churchyard, R. Cias, R. Dasa, C.L. Daley, P.N.R. Dekhuijzen, D. Domingo, F. Drobniewski, J. Esteban, M. Fauville-Dufaux, D.B. Folkvardsen, N. Gibbons, E. Gómez-Mampaso, R. Gonzalez, H. Hoffmann, P.R. Hsueh, A. Indra, T. Jagielski, F. Jamieson, M. Jankovic, E. Jong, J. Keane, W.J. Koh, B. Lange, S. Leao, R. Macedo, T. Mannsåker, T.K. Marras, J. Maugein, H.J. Milburn, T. Mlinkó, N. Morcillo, K. Morimoto, D. Papaventsis, E. Palenque, M. Paez-Peña, C. Piersimoni, M. Polanová, N. Rastogi, E. Richter, M.J. Ruiz-Serrano, A. Silva, M.P. da Silva, H. Simsek, D. van Soolingen, N. Szabó, R. Thomson, M.T. Tórtola Fernandez, E. Tortoli, S.E. Totten, G. Tyrrell, T. Vasankari, M. Villar, R. Walkiewicz, K. Winthrop, D. Wagner and for NTM-NET (www.ntm-net.org)Article | Published in 2013 in European Respiratory JournalW. HoefslootJakko van IngenC. AndrejakK. ÄngebyR. BauriaudP. BemerN. BeylisM.J. BoereeJ. CachoV. ChihotaE. ChimaraG. ChurchyardR. CiasR. DasaC.L. DaleyP.N.R. DekhuijzenD. DomingoF. DrobniewskiJ. EstebanM. Fauville-DufauxD.B. FolkvardsenN. GibbonsE. Gómez-MampasoR. GonzalezH. HoffmannP.R. HsuehA. IndraT. JagielskiF. JamiesonM. JankovicE. JongJ. KeaneW.J. KohB. LangeS. LeaoR. MacedoT. MannsåkerT.K. MarrasJ. MaugeinH.J. MilburnT. MlinkóN. MorcilloK. MorimotoD. PapaventsisE. PalenqueM. Paez-PeñaC. PiersimoniM. PolanováN. RastogiE. RichterM.J. Ruiz-SerranoA. SilvaM.P. da SilvaH. SimsekD. van SoolingenN. SzabóR. ThomsonM.T. Tórtola FernandezE. TortoliS.E. TottenG. TyrrellT. VasankariM. VillarR. WalkiewiczK. Winthrop
- Human-to-human transmission of Mycobacterium kansasii or victims of a shared source?By William M. Ricketts, Terence C. O’Shaughnessy and Jakko van IngenArticle | Published in 2014 in European Respiratory JournalWilliam M. Ricketts1Dept of Respiratory Medicine, Whittington Healthcare NHS Trust, London, UKTerence C. O’Shaughnessy2Dept of Respiratory Medicine, Barts Health NHS Trust, London, UKJakko van Ingen3Dept of Medical Microbiology, Radboud University Medical Centre, Nijmegen, the Netherlands
- Human-to-human transmission of Mycobacterium kansasii or victims of a shared source?By William M. Ricketts, Terence C. O’Shaughnessy and Jakko van IngenWilliam M. Ricketts1Dept of Respiratory Medicine, Whittington Healthcare NHS Trust, London, UKTerence C. O’Shaughnessy2Dept of Respiratory Medicine, Barts Health NHS Trust, London, UKJakko van Ingen3Dept of Medical Microbiology, Radboud University Medical Centre, Nijmegen, the Netherlands
- Annual prevalence and treatment estimates of nontuberculous mycobacterial pulmonary disease in Europe: A NTM-NET collaborative studyBy Dirk Wagner, Jakko van Ingen, Jennifer Adjemian, Christoph Lange, D. Rebecca Prevots, David Griffith, Jack Gallagher, Renu Gupta and Charles HaworthDirk Wagner1Division of Infectious Diseases and Center for Chronic Immunodeficiency, University Medical Center, Freiburg, GermanyJakko van Ingen2Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, NetherlandsJennifer Adjemian3Epidemiology Unit, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD,Christoph Lange4Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, GermanyD. Rebecca Prevots3Epidemiology Unit, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD,David Griffith5Pulmonary and Critical Care Division, The University of Texas Health Science Center, Tyler, TX,Jack Gallagher6Department of Analytics, Clarity Pharma Research, LLC, Spartanburg, SC,Renu Gupta7Clinical Development, Insmed Incorporated, Monmouth Junction, NJ,Charles Haworth8Centre for Lung Infection, Papworth Hospital, Cambridge, United Kingdom
- Comparison of treatment practices for nontuberculous mycobacterial pulmonary disease in Japan, Europe, and United StatesBy Jakko van Ingen, Jennifer Adjemian, Kozo Morimoto, Dirk Wagner, Christoph Lange, Charles Haworth, Jack Gallagher, D. Rebecca Prevots, Renu Gupta and David GriffithJakko van Ingen1Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, NetherlandsJennifer Adjemian2Epidemiology Unit, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD,Kozo Morimoto3Respiratory Disease Center, Fukujuji Hospital, Tokyo, JapanDirk Wagner4Division of Infectious Diseases and Center for Chronic Immunodeficiency, University Medical Center, Freiburg, GermanyChristoph Lange5Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, GermanyCharles Haworth6Cambridge Centre for Lung Infection, Papworth Hospital, Cambridge, United KingdomJack Gallagher7Department of Analytics, Clarity Pharma Research, LLC, Spartanburg, SC,D. Rebecca Prevots2Epidemiology Unit, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD,Renu Gupta8Clinical Development, Insmed Incorporated, Monmouth Junction, NJ,David Griffith9Pulmonary and Critical Care Division, The University of Texas Health Science Center, Tyler, TX,
- Stricter microbiological criteria are useful surrogate in estimating the prevalence of nontuberculous mycobacterial pulmonary disease in CroatiaBy Marko Jakopovic, Mateja Jankovic Makek, Ivan Sabol, Jakko Van Ingen, Ljiljana Zmak, Vera Katalinic-Jankovic, Brigita Ticac, Ljiljana Bulat-Kardum, Gzim Redzepi, Mirna Vranic-Ladavac and Miroslav SamarzijaMarko Jakopovic1Department for Lung Disease, University Hospital Center Zagreb, Zagreb, CroatiaMateja Jankovic Makek1Department for Lung Disease, University Hospital Center Zagreb, Zagreb, CroatiaIvan Sabol2Laboratory of Molecular Virology and Bacteriology, Ruder Boskovic Institute, Zagreb, CroatiaJakko Van Ingen3Department of Medical Microbiology, Radboud University Nijmegen Medical Centre, Nijmegen, NetherlandsLjiljana Zmak4National Mycobacteria Reference Laboratory, Croatian National Institute of Public Health, Zagreb, CroatiaVera Katalinic-Jankovic4National Mycobacteria Reference Laboratory, Croatian National Institute of Public Health, Zagreb, CroatiaBrigita Ticac5Mycobacteria Laboratory, Institute of Public Health, Rijeka, CroatiaLjiljana Bulat-Kardum6Department for Lung Diseases, Clinical Hospital Center Rijeka, Rijeka, CroatiaGzim Redzepi1Department for Lung Disease, University Hospital Center Zagreb, Zagreb, CroatiaMirna Vranic-Ladavac7Department of Microbiology, Istria County Public Health Institute, Pula, CroatiaMiroslav Samarzija1Department for Lung Disease, University Hospital Center Zagreb, Zagreb, Croatia
- A randomized, open-label, multicenter study of liposomal amikacin for inhalation in adult patients with nontuberculous mycobacteria (NTM) lung infections caused by mycobacterium avium complex (MAC)By David Griffith, Patrick Flume, Kevin Winthrop, Rachel Thomson, Dirk Wagner, Jakko Van Ingen, Liza Micioni, John P. McGinnis II, Carlos Fernandez and Gina EagleDavid Griffith1Department of Medicine, The University of Texas Health Science Center at Tyler, Tyler, TX United StatesPatrick Flume2Division of Pulmonary, Critical Care and Sleep Medicine, Medical University of South Carolina, Charleston, SC United StatesKevin Winthrop3Division of Infectious Diseases, Oregon Health & Science University, Portland, OR United StatesRachel Thomson4Thoracic Medicine, Gallipoli Medical Research Centre, Greenslopes Private Hospital, Brisbane, Queensland AustraliaDirk Wagner5Center of Infectious Diseases and Travel Medicine & Center for Chronic Immunodeficiency, University Medical Center, Freiburg, GermanyJakko Van Ingen6Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, NetherlandsLiza Micioni7Clinical, Insmed Incorporated, Bridgewater, NJ United StatesJohn P. McGinnis II7Clinical, Insmed Incorporated, Bridgewater, NJ United StatesCarlos Fernandez7Clinical, Insmed Incorporated, Bridgewater, NJ United StatesGina Eagle7Clinical, Insmed Incorporated, Bridgewater, NJ United States
- Volatile organic compounds emitted by pseudomonas aeruginosa and aspergillus fumigatus mono-cultures and in co-cultureBy Anne H. Neerincx, Brigitte Geurts, Jeroen J. Jansen, Marie-Fleur J. Habets, Johannes A. Booij, Jakko Van Ingen, Johan W. Mouton, Frans J.M. Harren, Leo A.J. Kluijtmans, Ron A. Wevers, Simona M. Cristescu and Peter J.F.M. MerkusAnne H. Neerincx1Department of Molecular and Laser Physics, Radboud University, Nijmegen, NetherlandsBrigitte Geurts2Department of Analytical Chemistry, Radboud University, Nijmegen, NetherlandsJeroen J. Jansen2Department of Analytical Chemistry, Radboud University, Nijmegen, NetherlandsMarie-Fleur J. Habets1Department of Molecular and Laser Physics, Radboud University, Nijmegen, NetherlandsJohannes A. Booij3Department of Paediatrics, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, NetherlandsJakko Van Ingen4Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, NetherlandsJohan W. Mouton4Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, NetherlandsFrans J.M. Harren1Department of Molecular and Laser Physics, Radboud University, Nijmegen, NetherlandsLeo A.J. Kluijtmans5Deparment of Laboratory Medicine, Translational Metabolic Laboratory, Radboud University Medical Center, Nijmegen, NetherlandsRon A. Wevers5Deparment of Laboratory Medicine, Translational Metabolic Laboratory, Radboud University Medical Center, Nijmegen, NetherlandsSimona M. Cristescu1Department of Molecular and Laser Physics, Radboud University, Nijmegen, NetherlandsPeter J.F.M. Merkus3Department of Paediatrics, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, Netherlands
- Systemic corticosteroid and inhalation corticosteroid therapy are associated with nontuberculous mycobacterial pulmonary diseaseBy Marko Jakopovic, Mateja Jankovic Makeke, Ivan Sabol, Jakko Van Ingen, Ljiljana Zmak, Andrea Vukic Dugac, Ana Hecimovic, Daniel Sekula, Drazen Strelec, Dina Mihelcic and Miroslav SamarzijaMarko Jakopovic1Department for Lung Diseases, University Hospital Center Zagreb, Zagreb, CroatiaMateja Jankovic Makeke1Department for Lung Diseases, University Hospital Center Zagreb, Zagreb, CroatiaIvan Sabol2Laboratory of Molecular Virology and Bacteriology, Ruder Boskovic Institute, Zagreb, CroatiaJakko Van Ingen3Department of Medical Microbiology, Radboud University Nijmegen Medical Centre, Nijmegen, NetherlandsLjiljana Zmak4National Mycobacteria Reference Laboratory, Croatian National Institute of Public Health, Zagreb, CroatiaAndrea Vukic Dugac1Department for Lung Diseases, University Hospital Center Zagreb, Zagreb, CroatiaAna Hecimovic1Department for Lung Diseases, University Hospital Center Zagreb, Zagreb, CroatiaDaniel Sekula5Department for Lung Diseases, General Hospital Zadar, Zadar, CroatiaDrazen Strelec6Department for Lung Diseases, Hospital for Lung Diseases and Tuberculosis, Klenovnik, CroatiaDina Mihelcic1Department for Lung Diseases, University Hospital Center Zagreb, Zagreb, CroatiaMiroslav Samarzija1Department for Lung Diseases, University Hospital Center Zagreb, Zagreb, Croatia
- Regimens for nontuberculous mycobacterial lung disease lack early bactericidal activityBy Michiel H.C. Slaats, Wouter Hoefsloot, Cecile Magis-Escurra, Martin J. Boeree, Melanie Wattenberg, Saskia Kuipers and Jakko van IngenArticle | Published in 2015 in European Respiratory JournalMichiel H.C. Slaats1Dept of Medical Microbiology, Radboud University Medical Center, Nijmegen, The NetherlandsWouter Hoefsloot2Dept of Respiratory Diseases, Radboud University Medical Center, Nijmegen, The NetherlandsCecile Magis-Escurra2Dept of Respiratory Diseases, Radboud University Medical Center, Nijmegen, The NetherlandsMartin J. Boeree2Dept of Respiratory Diseases, Radboud University Medical Center, Nijmegen, The NetherlandsMelanie Wattenberg1Dept of Medical Microbiology, Radboud University Medical Center, Nijmegen, The NetherlandsSaskia Kuipers1Dept of Medical Microbiology, Radboud University Medical Center, Nijmegen, The NetherlandsJakko van Ingen1Dept of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands
- Deficient interleukin-17 production in response to Mycobacterium abscessus in cystic fibrosisBy Katharina L. Becker, Jakko van Ingen, Jaap ten Oever, Peter J. Merkus, Gerben Ferwerda, Mihai G. Netea, Cecile Magis-Escurra, Monique H. Reijers and Frank L. van de VeerdonkArticle | Published in 2016 in European Respiratory JournalKatharina L. Becker1Dept of Internal Medicine, Radboud University Medical Centre, Nijmegen, The NetherlandsJakko van Ingen2Dept of Medical Microbiology, Radboud University Medical Centre, Nijmegen, The NetherlandsJaap ten Oever1Dept of Internal Medicine, Radboud University Medical Centre, Nijmegen, The NetherlandsPeter J. Merkus3Dept of Pediatrics, Division of Respiratory Medicine, Radboud University Medical Centre, Nijmegen, The NetherlandsGerben Ferwerda4Dept of Pediatrics, Laboratory of Pediatric Infectious Diseases, Radboud University Medical Centre, Nijmegen, The NetherlandsMihai G. Netea1Dept of Internal Medicine, Radboud University Medical Centre, Nijmegen, The NetherlandsCecile Magis-Escurra5Dept of Pulmonology, Radboud University Medical Centre, Nijmegen, The NetherlandsMonique H. Reijers5Dept of Pulmonology, Radboud University Medical Centre, Nijmegen, The NetherlandsFrank L. van de Veerdonk1Dept of Internal Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands
- Regimens for nontuberculous mycobacterial lung disease lack early bactericidal activityBy Michiel H.C. Slaats, Wouter Hoefsloot, Cecile Magis-Escurra, Martin J. Boeree, Melanie Wattenberg, Saskia Kuipers and Jakko van IngenMichiel H.C. Slaats1Dept of Medical Microbiology, Radboud University Medical Center, Nijmegen, The NetherlandsWouter Hoefsloot2Dept of Respiratory Diseases, Radboud University Medical Center, Nijmegen, The NetherlandsCecile Magis-Escurra2Dept of Respiratory Diseases, Radboud University Medical Center, Nijmegen, The NetherlandsMartin J. Boeree2Dept of Respiratory Diseases, Radboud University Medical Center, Nijmegen, The NetherlandsMelanie Wattenberg1Dept of Medical Microbiology, Radboud University Medical Center, Nijmegen, The NetherlandsSaskia Kuipers1Dept of Medical Microbiology, Radboud University Medical Center, Nijmegen, The NetherlandsJakko van Ingen1Dept of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands
- Deficient interleukin-17 production in response to Mycobacterium abscessus in cystic fibrosisBy Katharina L. Becker, Jakko van Ingen, Jaap ten Oever, Peter J. Merkus, Gerben Ferwerda, Mihai G. Netea, Cecile Magis-Escurra, Monique H. Reijers and Frank L. van de VeerdonkKatharina L. Becker1Dept of Internal Medicine, Radboud University Medical Centre, Nijmegen, The NetherlandsJakko van Ingen2Dept of Medical Microbiology, Radboud University Medical Centre, Nijmegen, The NetherlandsJaap ten Oever1Dept of Internal Medicine, Radboud University Medical Centre, Nijmegen, The NetherlandsPeter J. Merkus3Dept of Pediatrics, Division of Respiratory Medicine, Radboud University Medical Centre, Nijmegen, The NetherlandsGerben Ferwerda4Dept of Pediatrics, Laboratory of Pediatric Infectious Diseases, Radboud University Medical Centre, Nijmegen, The NetherlandsMihai G. Netea1Dept of Internal Medicine, Radboud University Medical Centre, Nijmegen, The NetherlandsCecile Magis-Escurra5Dept of Pulmonology, Radboud University Medical Centre, Nijmegen, The NetherlandsMonique H. Reijers5Dept of Pulmonology, Radboud University Medical Centre, Nijmegen, The NetherlandsFrank L. van de Veerdonk1Dept of Internal Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands
- TuberculosisEdited by Giovanni Battista Migliori, Graham Bothamley, Raquel Duarte and Adrian RendonBook | Published in 2018DOI: 10.1183/2312508X.erm8218ISBN (electronic): 978-1-84984-100-9Giovanni Battista MiglioriGraham BothamleyRaquel Duarte
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.